Overview

Subarachnoid Administration of Levobupivacaine for Cesarean Section

Status:
Unknown status
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the investigators study is to compare the clinical effects and side-effects of these three local anaesthetics as sole agents or with the supplementation with fentanyl for c-section, especially when administered in doses achieving approximately an ED 50.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Patras
Treatments:
Bupivacaine
Fentanyl
Levobupivacaine
Ropivacaine